Jain, Neeraj
Mamgain, Mukesh
Chowdhury, Sayan Mullick
Jindal, Udita
Sharma, Isha
Sehgal, Lalit
Epperla, Narendranath
Funding for this research was provided by:
National Institutes of Health (R01CA282483)
Article History
Received: 19 July 2023
Accepted: 21 August 2023
First Online: 25 August 2023
Declarations
:
: Not applicable.
: The authors permit the Journal of Hematology and Oncology to publish this work.
: NE: Research funding from Beigene, Speakers Bureau for Beigene, Incyte, and Novartis, and Honoraria/consulting/ad boards for Merck, ADC Therapeutics, Lilly, and Novartis. The other co-authors do not have no relevant competing interests.